Oxygen Therapy Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 41.63 Bn

Forecast Year, 2035

USD 70.01 Bn

CAGR, 2026 - 2035

5.34%

Report Coverage

Global

What is Oxygen Therapy Market Size?

The global oxygen therapy market size is calculated at USD 41.63 billion in 2025 and is predicted to increase from USD 43.87 billion in 2026 to approximately USD 70.01 billion by 2035, expanding at a CAGR of 5.34% from 2026 to 2035.

Oxygen therapy is used for the treatment of both acute and chronic illnesses such as chronic obstructive pulmonary disease (COPD), pneumonia, and asthma. This therapy helps maintain the blood's oxygen level. People with COPD often benefit from long-term oxygen therapy. Cystic fibrosis, dysplasia, heart failure, sleep apnea, and lung abnormalities are a few other acute or chronic medical conditions when oxygen therapy is helpful. Some individuals only require it temporarily, and some need ongoing oxygen therapy.

Market Highlights

• By geography, the North America dominated the market and generated more than 33% revenue share in 2025.
• By product, the oxygen source equipment segment made up the biggest percentage in 2025.
• By portability, the stationary oxygen therapy equipment devices segment is predicted to dominate the market.
• By application, the chronic obstructive pulmonary disorder (COPD) segment generated more than 36% in 2025.

Market Size and Forecast

• Market Size in 2025: USD 41.63 Billion
• Market Size in 2026: USD 43.87 Billion
• Forecasted Market Size by 2035: USD 70.01Billion
• CAGR (2026-2035): 5.34%
• Largest Market in 2025: North America
• Fastest Growing Market: Asia Pacific

Growth Factors

The main drivers of the market are the rising incidence of persistent respiratory disorders and the rising demand for home healthcare. Nearly 12 million adult Americans have been diagnosed with COPD, and 120,000 people die from it each year, according to the National Institutes of Health (NIH). The market for these goods is anticipated to increase as the patient population grows. In the ensuing years, the sector is expected to be driven by this subsequent rise in demand.

• Increasing incidence of various chronic respiratory disorders
• Increasing acceptance of home oxygen therapy
• Growing geriatric population
• Increasing Organizational Initiative Regarding Respiratory Diseases
• Rapidly increasing hospital infrastructure in developing countries
• Increased demand during Covid-19

Market Scope

Market Dynamics

Drivers

The surge in the latest oxygen therapy solutions

The demand for the most minor, durable portable oxygen solutions is rising. Patients are less likely to adhere to their therapy using portable home oxygen therapy equipment because they prefer to avoid carrying around a heavy, cumbersome oxygen device. However, the improvement of battery life is one of the areas where there have been considerable advancements in oxygen-conserving methods and lithium-ion battery technology in recent years.

The most recent versions of portable oxygen concentrators weigh just 5-7 pounds and, depending on the litre flow settings chosen by each patient, can provide oxygen therapy for up to 8–13 hours after a battery charge.

Manufacturers of portable oxygen concentrators are also aiming for silent compressor motors, which would reduce noise pollution in small places. The most effective use of dosing technology has allowed portable oxygen concentrator manufacturers to improve performance features, enabling more current designs to increase the units' lifespan beyond occasional use and become dependable and durable for a consistent five-year cycle.

Restraint

Frequent adverse effects:

The market expansion for oxygen treatment is being constrained by their unfavorable side effects, which, when used therapeutically, include skin irritation and nasal dryness. Dryness of the nose and skin irritation are two of the most typical side effects of oxygen therapy. The cannula may rub against the skin and create irritation.

The nasal passages are dried out by oxygen therapy, which increases the risk of nasal dryness and nosebleeds. Oxygen toxicity, brought by inappropriate or excessive supplemental oxygen, can seriously harm the lungs and other organ systems. Long-term exposure to high oxygen concentrations can enhance free radical production and cause lung injury.

The range of lung ailments it can induce includes minor tracheobronchitis and widespread alveolar damage. As a result, this may hinder the expansion of the oxygen therapy market.

Opportunity

Technology advancements in therapeutic equipment:

Due to the increase in individuals with respiratory conditions who practically need oxygen therapy devices (OTD), the pressure on healthcare facilities to handle patients who need OTD constantly is fueling the market for oxygen therapy. As wearable technology develops with improvements in Photoplethysmography (PPG) sensors and wireless 5G connectivity, it is anticipated that the trend of digital health data transfer for oxygen therapy monitoring will increase rapidly.

PPG is a non-invasive device that measures volumetric fluctuations in blood circulation by using a light source and a photodetector at the skin's surface. Only specific body parts, including the fingertips, earlobes, and forehead, can accommodate wearable PPG sensors. Additionally, patients can become more involved in the success of their care with the rising use and adoption of remote patient monitoring systems and the proper instruction in their use. The aforementioned aspects will give the market profitable prospects.

Segment Insights

Product Insights

Due to its high availability and utilization in the form of O2 concentrators, compressed gas systems, cylinders, and liquid oxygen, oxygen source equipment made up the highest percentage in 2023. Additionally, these devices serve as the primary source and first step in O2 therapy, playing a crucial role in the industry's overall growth.

The oxygen concentrators segment of the oxygen source equipment market is anticipated to grow profitably. Transportable concentrators are expected to have a high growth potential due to their use in ambulances, trains, and aeroplanes, as well as their application in various medical emergencies, which will support this segment's potential demand.

Over the next few years, it is anticipated that demand will increase due to the growing acceptance and popularity of on-demand & continuous Portable Oxygen Concentrators (POC) in various applications, including emergency medicine. This increase is linked to the entry of international rivals, consumer desire for portable technology, and the urgent clinical need for more mobility support for the senior population. The firm is expected to grow due to ongoing innovation, which produces more effective units and lower prices.

Due to the accessibility of various delivery methods tailored to different patients' physiological and inspiratory needs, the oxygen delivery devices market is predicted to grow at a profitable rate. In the upcoming years, demand is anticipated to be aided by prospective benefits such as consistent O2 flow, variable pressure, exclusion of complicated masks, and flow dilution.

Portability Insights

The stationary oxygen therapy equipment devices category is predicted to lead the market in portability during the study period. Because most patients receiving treatment are confined to beds, the fixed oxygen therapy equipment market is driven and will account for maximum market revenue during the projection period.

Due to a rising population base, favorable reimbursement policies, and a low mobility profile, this category is expanding. Long-term oxygen therapy (LTOT) equipment used in residential settings is expected to enhance demand for oxygen therapy equipment over the projected period.

Application Insights

Due to the rising prevalence of COPD, the chronic obstructive pulmonary disorder (COPD) segment will hold a share of about 36% in 2025. According to the WHO, COPD affects about 65 million people worldwide and is the third most significant cause of death. The clinical need for COPD treatment is driven by the disease's increasing prevalence, which is helping the industry grow.

Regional Insights

What is the U.S. Oxygen Therapy Market Size?

The U.S. oxygen therapy market size is estimated at USD 9.62 billion in 2025 and is expected to be worth around USD 16.63 billion by 2035, rising at a CAGR of 5.63% from 2026 to 2035.

With a revenue share of over 33% in 2025,North America dominated the market thanks to extensive O2 treatment research and development activities. For instance, the British Medical Research Council and North American Nocturnal Oxygen Therapy conducted studies to determine the efficacy of long-term O2 therapy.

The increasing use of topical wound oxygen therapy (TWO) and hyperbaric oxygen therapy in this region also impact market demand. Due to urbanization and occupational risks, this region also has a higher risk of developing respiratory illnesses, which is anticipated to spur market growth throughout the projection period.

U.S. Oxygen Therapy Market Trends

The U.S. oxygen therapy industry is growing due to the high prevalence of respiratory diseases like COPD and asthma. Increasing use of home healthcare and portable oxygen devices is a key trend. Technological advancements are improving treatment and patient monitoring.

During the forecast period, Asia Pacific is projected to have exponential growth. High R&D spending by international manufacturers and the rising commercialization of O2 therapy devices created by these firms are the market's primary drivers. Additionally, throughout the projected period, the firm is expected to benefit from lucrative growth potential due to the urgent need to create new technologies and replace and update medical infrastructure.

Ongoing technological advancements, growing international collaboration and expanding distribution networks fuel the development of O2 therapy in this area.

China Oxygen Therapy Market Trends

The Chinese oxygen therapy industry is expanding rapidly due to the rising prevalence of respiratory diseases and an aging population. Increasing demand for home healthcare and portable oxygen devices is driving market growth. Technological advancements and improved healthcare infrastructure are further supporting the wider adoption of oxygen therapy solutions.

What are the Advancements in the Oxygen Therapy Industry in Europe?

Europe shows a significant growth during the forecast period. It is driven by a surge in chronic respiratory diseases, an aging population, along with the demand to reduce the high economic and even societal burden of lung conditions. The pandemic highlighted the demand for stronger respiratory care, forcing a change from emergency responses to long-term management of respiratory conditions, which includes the management of long COVID.

Germany Oxygen Therapy Market Trends: The country's market landscape is driven by increasing healthcare expenditure and a growing awareness of respiratory health. The region also benefits from robust regulatory frameworks that help to promote innovation and ensure patient safety.

What are the Key Trends in the Oxygen Therapy Industry in Latin America?

Latin America shows a notable growth during the forecast period. It is driven by overcapacity in hospitals, high expenses, rising chronic disease rates among an aging population, along with a cultural preference for family-centered care. Moreover, this transition is necessitated by strained public healthcare systems along with the demand for long-term management outside of acute care settings. Limited ICU beds along with suboptimal technology in public hospitals make long-term hospitalization impossible, forcing the demand for home-based alternatives.

Brazil Oxygen Therapy Market Trends: The region's growth and development are driven by various factors such as rising pollution levels, increasing incidence of chronic respiratory diseases, and a growing elderly population. Additionally, government initiatives aimed at improving healthcare infrastructure are expected to further boost market growth even further.

Expanding adoption of home-based oxygen therapy and portable devices is a key market trend. Technological advancements and strong healthcare infrastructure are supporting continued market growth.

How is the Middle East and Africa Region Growing in the Oxygen Therapy Industry?

MEA shows a rapid growth during the forecast period. The region is investing hundreds of billions of dollars to become a global centre for Artificial Intelligence, smart city development, and green technology. AI is being integrated into healthcare, diagnostics, energy optimization, and urban planning. Moreover, humanoid robots are changing from labs into public service and industry roles.

Saudi Arabia Oxygen Therapy Market Trends: The region's growth and development are primarily being driven by increasing healthcare investments and a rising prevalence of respiratory conditions. Companies in the region are seen actively focusing on establishing distribution networks and partnerships to enhance market penetration. The country's market landscape is characterized by a mix of local and global players, all aiming to address the region's unique healthcare needs.

Oxygen Therapy Market Companies

• Linde Healthcare: Linde Healthcare provides a comprehensive portfolio for the oxygen therapy market, thus spanning the entire care continuum from hospital to home. Their offerings aim on providing high-purity medical oxygen, specialized delivery equipment, together with integrated services to guarantee patient safety and efficiency.
• Chart Industries, Inc.: Chart Industries, Inc. provides services mainly in the production, storage, and distribution of liquid oxygen and, via its CAIRE brand, offers portable and stationary oxygen concentrators. Their solutions thus cater to both the home healthcare market and institutional medical facilities.
• Invacare Corporation : Invacare Corporation is a key player in the respiratory care market, providing a comprehensive portfolio of oxygen therapy solutions aimed at both stationary and portable, as well as non-delivery oxygen systems.
• Smiths Medical: Smiths Medical provides a comprehensive range of oxygen therapy solutions primarily via their Portex and O2FLO product lines, catering to hospital, emergency, and home care environments. Their portfolio focuses on high-flow therapy, patient comfort, and precise oxygen delivery.

Other Major Key Players

• Philips Healthcare
• Becton, Dickinson, and Company
• Dragerwerk AG & Co. KGaA
• Teleflex Incorporated
• Fisher & Paykel Healthcare Corporation Limited
• DeVilbiss Healthcare
• HERSILL, S.L.
• GCE Holding AB

Segments Covered in the Report

By Product

• Oxygen Source Equipment
  • Oxygen Therapy Equipment for Cardiovascular & Thoracic Surgeries
  • Oxygen Concentrators
  • Liquid Oxygen
  • Oxygen Cylinders
• Oxygen Delivery Devices
  • Oxygen Masks
  • Nasal Cannulas
  • Venturi Masks
  • Non-Rebreather Masks
  • Bag-Valve Masks
  • Other Oxygen Delivery Devices

By Portability

• Stationary Oxygen Therapy Equipment Devices
• Portable Oxygen Therapy Equipment Devices

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma
• Obstructive Sleep Apnea
• Respiratory Distress Syndrome
• Cystic Fibrosis
• Pneumonia
• Others

ByGeography

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa